AzTrials
AzTrials

Major DepressionNCT02119975

A Working Memory Training to Decrease Rumination in Depressed and Anxious Individuals

A study testing Working memory training in people with Major Depression and Anxiety Disorder, run by Erasmus Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Dysfunctioning executive functioning, including working memory (WM), is related to rumination. Findings show that working memory capacity (WMC) can be increased by training. The current study explored by means of a double-blind randomized controlled trial whether an adaptive WM training could reduce rumination… Read more about this study

Who is it for?
Ages 18 to 67 years
Conditions the study is for
Major Depression, Anxiety Disorder
What is being tested?
Working memory training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
98 participants
Where
1 siteNetherlands
Study dates
Aug 2011to Dec 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 67 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Major depression diagnosis
  • Anxiety diagnosis

Who cannot join

  • Current psychosis
  • Substance abuse

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Erasmus University Rotterdam

    Rotterdam, South Holland, 3000 DR

Other trials in Netherlands

About this study

Official title: A Working Memory Training to Decrease Rumination in Depressed and Anxious Individuals: A Double-blind Randomized Controlled Trial

Dysfunctioning executive functioning, including working memory (WM), is related to rumination. Findings show that working memory capacity (WMC) can be increased by training. The current study explored by means of a double-blind randomized controlled trial whether an adaptive WM training could reduce rumination, anxiety and depression in a sample of 98 depressed and anxious individuals.

Being tested
Working memory training, Placebo training
Keywords
Rumination, Working memory, Depression, Anxiety, Working memory training, Overgeneral memories
Medical subject headings
Depressive Disorder, Major, Anxiety Disorders, Rumination Syndrome, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Working memory trainingBehavioural

  • Placebo trainingBehavioural

Study groups in NCT02119975
Study groupRoleWhat they receive
Placebo working memory trainingPlacebo comparatorNot described
Receives: Behavioral: Placebo training
Working memory trainingExperimentalNot described
Receives: Behavioral: Working memory training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Ruminative Response Scale (RRS) score from pre to post training and after two months (follow up 2)

    Dutch version; Raes, Hermans, \& Eelen, 2003) measures the frequency of self-reported rumination behavior, with answer options ranging from 1 (never) to 4 (always). The total score of the 22 items was used in the analyses.

    Measured: Pre training (baseline), post training (4 weeks after baseline, training starts 1 day after baseline) and follow-up (2 months after post-test)

Secondary outcomes (2)
  1. Change in Beck Depression Inventory Second Edition (BDI-II) score from pre to post training and after two months (follow up 2)

    The Beck Depression Inventory - II (BDI-II; Beck, Steer, \& Brown, 1996; Dutch version: Van der Does, 2002) measures the severity of depression symptoms of the last two weeks.

    Measured: Pre training (baseline), post training (4 weeks after baseline, training starts 1 day after baseline) and follow-up (2 months after post-test)

  2. Change in State-Trait Anxiety Inventory (STAI) score from pre to post training and after two months (follow up 2)

    The State-Trait Anxiety Inventory (STAI; Spielberger, Gorsuch, Lushene, Vagg, \& Jacobs, 1983, Dutch version; Van der Ploeg, Defares, \& Spielberger, 1979) measures self-reported anxiety, divided in state anxiety and trait anxiety.

    Measured: Pre training (baseline), post training (4 weeks after baseline, training starts 1 day after baseline) and follow-up (2 months after post-test)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2014 (estimated)
  2. Study startAug 2011
  3. Primary completionDec 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
98 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02119975
Sponsor's protocol ID
4
Status last verified
Apr 2014
First submitted
8 Apr 2014
Last updated
22 Apr 2014
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Working memory training in people with Major Depression and Anxiety Disorder, run by Erasmus Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Apr 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Ruminative Response Scale (RRS) score from pre to post training and after two months (follow up 2) (time frame: Pre training (baseline), post training (4 weeks after baseline, training starts 1 day after baseline) and follow-up (2 months after post-test)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2014; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in